| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |